Return to search results
Invisible Illness — TOPx HHS 2026 Focus Area
The Invisible Illness focus area is intentionally broad and inclusive. Invisible illness may include, but is not limited to, autoimmune conditions, mental health and behavioral health conditions, suicide prevention, Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), infection-associated chronic conditions (IACCs), Lyme disease and other tickborne diseases, and other conditions that may not be immediately visible or outwardly apparent.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[ "009:00" ] |
| contactPoint |
{ "fn": "Office of the Chief Data Officer", "@type": "vcard:Contact", "hasEmail": "mailto:healthdata@hhs.gov" } |
| description | The Invisible Illness focus area is intentionally broad and inclusive. Invisible illness may include, but is not limited to, autoimmune conditions, mental health and behavioral health conditions, suicide prevention, Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), infection-associated chronic conditions (IACCs), Lyme disease and other tickborne diseases, and other conditions that may not be immediately visible or outwardly apparent. |
| identifier | https://healthdata.gov/api/views/w6hy-npne |
| issued | 2026-05-28 |
| keyword |
[ "accelerator", "adaptive", "ai", "artificial intelligence", "challenge", "chronic", "chronic condition", "chronic conditions", "citizen science", "clinical guidelines", "co-creation", "cocreate", "crowdsource", "diagnostic", "diagnostics", "evidence-based", "exponential", "grand-prize challenge", "iacc", "iacci", "iaci", "infection-associated chronic condition", "infection-associated chronic conditions", "infection-associated chronic conditions and illnesses", "infection-associated chronic illness", "infection-associated chronic illnesses", "innovation", "invisible illness", "invisible illnesses", "living clinical guidelines", "living evidence", "living guidelines", "lyme", "lyme ai", "lyme disease", "lyme innovation", "lymex", "lymex ai", "next-gen", "next-generation", "open data", "open gov", "open government", "open innovation", "open science", "open source", "partnership", "partnerships", "persistent symptoms", "post-treatment", "post-treatment lyme disease syndrome", "prize", "ptlds", "public-private", "tick", "tick-borne", "tickborne", "transparency", "vector", "vector-borne" ] |
| landingPage | https://healthdata.gov/d/w6hy-npne |
| modified | 2026-05-28 |
| programCode |
[ "009:000" ] |
| publisher |
{ "name": "Office of the Chief Data Officer", "@type": "org:Organization" } |
| title | Invisible Illness — TOPx HHS 2026 Focus Area |
